Pfizer and BioNTech Announce Collaboration on mRNA Shingles Vaccines

A vial and syringe are seen in front of the Pfizer and BioNTech logos in a file photo. Dado Ruvic/Reuters

Pfizer and its German partner on Tuesday announced they will work together on a shingles vaccine that utilizes messenger RNA technology.

Pfizer and BioNTech created one of the most-used COVID-19 vaccines in the world by using the technology, which had never been cleared for use in any countries before the pandemic.